The effect of different apheresis modalities on coagulation factor XIII level during antibody removal in ABO-blood type incompatible living related renal transplantation

Transfusion and Apheresis Science

Volumn 49, Issue 2, 2013, Pages 254-258

  Hanafusa, Norio ^a   Hamasaki, Yoshifumi ^a,b   Kawarasaki, Hiroo ^c   Kido, Ryo ^a   Shibagaki, Yugo ^c   Ishikawa, Akira ^d   Enomoto, Yutaka ^b   Fujita, Toshiro ^a   Noiri, Eisei ^a   Nangaku, Masaomi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE HOSPITAL   (Japan)

^d TOKYO TEISHIN HOSPITAL   (Japan)

Author keywords

Antibody removal; Coagulation factor XIII; Double filtration plasmapheresis; Living related; Renal transplantation; Simple plasma exchange

Indexed keywords

BLOOD CLOTTING FACTOR 8; FRESH FROZEN PLASMA; HEMOGLOBIN; RITUXIMAB;

ADULT; ANTIBODY ISOLATION; APHERESIS; ARTICLE; BLEEDING; BLOOD GROUP ABO INCOMPATIBILITY; CASE STUDY; CLINICAL ARTICLE; ERYTHROCYTE TRANSFUSION; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HEMOPHILIA A; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER DISEASE; MALE; PERIOPERATIVE PERIOD; PLASMAPHERESIS; SUPPLEMENTATION; THROMBOCYTE TRANSFUSION;

ANTIBODY REMOVAL; COAGULATION FACTOR XIII; DOUBLE FILTRATION PLASMAPHERESIS; LIVING RELATED; RENAL TRANSPLANTATION; SIMPLE PLASMA EXCHANGE;

ABO BLOOD-GROUP SYSTEM; ADULT; ALLOGRAFTS; BLOOD COMPONENT REMOVAL; FACTOR VIII; FEMALE; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES;

EID: 84886639056     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.06.004     Document Type: Article

References (21)

1. Tanabe K., Takahashi K., Sonda K., Tokumoto T., Ishikawa N., Kawai T., et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation 1998, 65:224-228.
2. Hume D.M., Merrill J.P., Miller B.F., Thorn G.W. Experiences with renal homotransplantation in the human: report of nine cases. J Clin Invest 1955, 34:327-382.
3. Slapak M., Naik R.B., Lee H.A. Renal transplant in a patient with major donor-recipient blood group incompatibility: reversal of acute rejection by the use of modified plasmapheresis. Transplantation 1981, 31:4-7.
4. Alexandre G.P., Squifflet J.P., De Bruyere M., Latinne D., Reding R., Gianello P., et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transpl Proc 1987, 19:4538-4542.
5. Takahasi K., Ota K., Ooba S., Tanabe K., Fuchinoue S., Honda H., et al. Use of a novel immunosuppressive agent, deoxyspergualin, in a case of ABO-incompatible kidney transplantation. Clin Transpl 1989, 306-307.
6. Tyden G., Kumlien G., Genberg H., Sandberg J., Lundgren T., Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transpl 2005, 5:145-148.
7. Agishi T., Takahashi K., Yagisawa T., Ota K. Immunoadsorption of anti-A or anti-B antibody for successful kidney transplantation between ABO incompatible pairs and its limitation. Jpn Biosynsorb Res Group. ASAIO Trans 1991, 37:M496-M498.
8. Wahrmann M., Schiemann M., Marinova L., Kormoczi G.F., Derfler K., Fehr T., et al. Anti-A/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorption. Nephrol Dial Transpl 2012, 27:2122-2129.
9. Tanabe K., Takahashi K., Agishi T., Toma H., Ota K. Removal of anti-A/B antibodies for successful kidney transplantation between ABO blood type incompatible couples. Transfus Sci 1996, 17:455-462.
10. Tanabe K. Double-filtration plasmapheresis. Transplantation 2007, 84:S30-S32.
11. Agishi T., Kaneko I., Hasuo Y., Hayasaka Y., Sanaka T., Ota K., et al. Double filtration plasmapheresis. Trans Am Soc Artif Intern Organs 1980, 26:406-411.
12. Hanafusa N. Theoretical basis of pathogenic substance removal during plasmapheresis. Therapeutic apheresis and dialysis: official peer-reviewed. J Int Soc Apheresis, Jpn Soc Apheresis, Jpn Soc Dial Ther 2011, 15:421-430.
13. Hanafusa N., Kondo Y., Suzuki M., Nakao A., Noiri E., Fujita T. Double filtration plasmapheresis can decrease factor XIII activity. Ther Apher Dial 2007, 11:165-170.
14. Gerlach R., Raabe A., Zimmermann M., Siegemund A., Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 2000, 54:260-264.
15. Mineshima M., Agishi T., Hasuo Y., Era K., Suzuki T., Teraoka S., et al. Optimum albumin concentration of supplementation fluid for double filtration plasmapheresis. Artif Organs 1992, 16:510-513.
16. Board P.G., Losowsky M.S., Miloszewski K.J. Factor XIII: inherited and acquired deficiency. Blood Rev 1993, 7:229-242.
17. Tosetto A., Castaman G., Rodeghiero F. Acquired plasma factor XIII deficiencies. Haematologica 1993, 78:5-10.
18. Seishima M., Shibuya Y., Kato G., Aoki T. Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis. Ther Apher Dial 2009, 13:229-231.
19. Hanafusa N., Aozasa N., Fujita T. A patient whose factor XIII level was decreased by double filtrate plasmapheresis and successfully recovered by infusion of factor XIII concentrate. Ther Apher Dial 2010, 14:432-433.
20. Mokrzycki M.H., Kaplan A.A. Therapeutic plasma exchange: complications and management. Am J Kidney Dis 1994, 23:817-827.
21. Renner F.C., Czekalinska B., Kemkes-Matthes B., Feustel A., Stertmann W.A., Padberg W., et al. Postoperative bleeding after AB0-incompatible living donor kidney transplantation. Transpl Proc 2010, 42:4164-4166.